Monte Rosa Therapeutics Inc — Dividend History & Yield (NASDAQ:GLUE) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Dividends per share ———— — Dividend yield % ———— — Payout ratio % ———— —

News

Monte Rosa shares rise on prostate cancer trial results

Monte Rosa reports positive trial data for prostate cancer drug

NeoGenomics (NEO) Q4 Earnings and Revenues Surpass Estimates

Monte Rosa stock price target raised to $37 from $27.50 at Piper Sandler

Monte Rosa Therapeutics prices $300 million public offering

GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug

Monte Rosa Therapeutics (GLUE) is on the Move, Here's Why the Trend Could be Sustainable

Monte Rosa Therapeutics launches $200 million public offering

Monte Rosa stock rises as TD Cowen reiterates Buy rating on NEK7 degrader data

Monte Rosa stock price target raised to $31 by Jefferies on NEK7 degrader data

Eli Lilly and Regencell among market cap stock movers on Wednesday

Monte Rosa Therapeutics (GLUE) Upgraded to Strong Buy: Here's Why